Zydus Lifesciences bags FDA final approval for Apixaban Tablets

Pallavi Madhiraju- March 1, 2023 0

Zydus Lifesciences has bagged final approval from the US Food and Drug Administration (FDA) for Apixaban Tablets, 2.5mg and 5mg, a generic version of Eliquis ... Read More

Zydus Lifesciences gets FDA final approval for Pitavastatin Tablets

Pallavi Madhiraju- February 26, 2023 0

Zydus Lifesciences said that it has bagged final approval for Pitavastatin Tablets, 1mg, 2mg, and 4mg from the US Food and Drug Administration (FDA). Pitavastatin ... Read More

Zydus Lifesciences gets FDA tentative approval for Invokamet generic

Pallavi Madhiraju- February 22, 2023 0

Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has been granted tentative approval for Canagliflozin and Metformin Hydrochloride Tablets, 50mg/500mg, 50mg/1,000mg, 150mg/500mg, and 150mg/1,000mg ... Read More

Zydus Lifesciences gets FDA tentative approval for Gabapentin Tablets

Pallavi Madhiraju- February 20, 2023 0

Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for once-daily Gabapentin Tablets, 300 mg and 600 mg from the US ... Read More

Zydus Lifesciences gets FDA final approval for Rapamune generic – Sirolimus Tablets

Pallavi Madhiraju- February 17, 2023 0

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) for Sirolimus Tablets, 1 mg and 2 mg, which is the ... Read More